Per Grimfjärd

Bivalirudin versus Heparin Monotherapy in Myocardial Infarction

David Erlinge, Elmir Ömerovic, Ole Fröbert et al. · New England Journal of Medicine · 2017 · 295 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

Sunil V. Rao, Bodo Kirsch, Deepak L. Bhatt et al. · Circulation · 2022 · 148 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Experience in treatment of metastatic pulmonary carcinoid tumors

Donald Granberg, B. Eriksson, Erik Wilander et al. · Annals of Oncology · 2001 · 144 citations · Full text

Medicine, Oncology, Surgery +12

Transfection of the Multiple Endocrine Neoplasia Type 1 Gene to a Human Endocrine Pancreatic Tumor Cell Line Inhibits Cell Growth and Affects Expression of JunD, δ-Like Protein 1/Preadipocyte Factor-1, Proliferating Cell Nuclear Antigen, and QM/Jif-1

Peter Stålberg, Per Grimfjärd, Mårten Santesson et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 55 citations · Full text

Medicine, Molecular Biology, Oncology +14

Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic

Moman A. Mohammad, Sasha Koul, Göran Olivecrona et al. · Heart · 2020 · 55 citations · Full text

Medicine, Cardiology, Internal Medicine +17